Journal article
Preliminary results of a two stage phase II study of 18F-DCFPyL PET-MR for enabling oligometastases ablative therapy in subclinical prostate cancer.
Abstract
250
Authors
Glicksman R; Metser U; Vines D; Chan R; Valliant J; Chung PWM; Gospodarowicz MK; Bayley A; Catton CN; Warde PR
Journal
Journal of Clinical Oncology, Vol. 37, No. 7_suppl, pp. 250–250
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2019
DOI
10.1200/jco.2019.37.7_suppl.250
ISSN
0732-183X